Southport Reporter (R) Bourder
Southport & Mersey Reporter - Mobile

Click on here to go to latest edition's main page.

  Search Edition Archive  

Visit our online shop...


Click on to go to our hub website.

Latest Edition   Archive   Shop   Email   Mersey Reporter
Please support our advertiser below...

For more recommended businesses click on here...

Weekly Edition - Publication date:- 2016-12-09

-en Southport & Mersey Reporter

Local News Report  - Mobile Page


Liverpool region awarded £3.4m to translate the latest science into new medical treatments

AN important milestone for medical research in Liverpool has been reached after a partnership involving the University and 2 local NHS Trusts was successful in securing £3.4m in funding for translational medicine research. The funding, provided by the National Institute for Health Research (NIHR), will support the infrastructure costs for early translational (experimental medicine) research to help speed up the translation of scientific advances for the benefit of patients. Translational medicine is a rapidly growing discipline in biomedical research and aims to 'speed up' the discovery of new diagnostic tools and treatments. This is done by using a multi disciplinary, highly collaborative, "bench to bedside" approach that sees research done in the laboratory directly used to develop new ways to treat patients. The applications for the funding were made by the Royal Liverpool and Broadgreen University Hospitals Trust, led by Dr Richard Fitzgerald, and Alder Hey Children's NHS Foundation Trust, led by Professor Michael Beresford, in partnership with the University of Liverpool.

The Clinical Research Unit at the Royal Liverpool University Hospital, which carries out 30 early phase research studies a year, received ?1.4million enabling more early phase and experimental medicine research; bringing new therapies, devices and diagnostics to patients more quickly.

Aidan Kehoe, chief executive of the Royal Liverpool and Broadgreen University Hospitals NHS Trust, said:- "We are proud to receive recognition from NIHR as it shows that our patients are attending a hospital that is at the forefront of clinical research. We have a strong history of carrying out research which is vital to improving the quality of lives of patients around the world. This will be further enhanced with the opening of the new Royal Liverpool University Hospital and development of the Liverpool Health Campus which will devote 100,000 square metres to life sciences, within the heart of the Knowledge Quarter."

Trish Pegg, 53, from Neston, volunteered to take part in clinical research at the Royal after her late husband was given 12 more years of life thanks to treatment made available after clinical testing. Trish said:- "By being part of the research, I wanted other families to benefit like ours did. As well as saying thank you, this was an opportunity to give something back and be part of the work that goes into finding a life changing treatment for the illness."

Every year thousands of children at Alder Hey participate in clinical studies to help find new medicines and treatments for children with both common and rare childhood illnesses. From the funding Alder Hey has received £2m to help two specific units supporting research within the brand new Alder Hey in the Park children's healthcare campus, the Clinical Research Facility and the Institute in the Park. Sir David Henshaw, Chair of Alder Hey Children's NHS Foundation Trust said:- "We have great ambitions to improve the health of children everywhere by creating a unique environment where ideas can flourish and be tried out in a real-world hospital environment. This recognition of our NIHR Alder Hey Clinical Research Facility is vital to this mission and we are delighted to have been selected. "

Professor Sir Munir Pirmohamed, who is Associate Pro-Vice Chancellor for Clinical Research at the University of Liverpool, and Executive Director of Liverpool Health Partners said:- "Once again these successful funding applications highlight the strengths of clinical research and the NHS-University partnerships in Liverpool.  Our translational research is underpinned by a critical mass of expertise and internationally renowned externally funded centres of excellence, and world class research facilities that pull research in basic science through to clinical application. Today's health research is tomorrow's healthcare so I am delighted that this funding will enable us to further progress more research and development in this exciting field."


News Report Page Quick Flick.

Click on here to go to the mobile menu page for this edition. News Report Page Quick Flick

Read this page.

Southport Reporter (R) Bourder




 RSS Our Weekly Headlines


(+44)  08443 244 195
Calls to this number may be recorded for security, broadcast, training and record keeping.

4a Post Office Ave, Southport, Merseyside, PR9 0US, UK


Click on to see our Twitter Feed.  Click on to see our Facebook Page.  Click on to follow our LinkedIn Profile. This website is licence to carry news from and UK Press Photography. 

This is our media complains system...

We are regulated by IMPRESS, the independent monitor for the UK's press.

How to make a complaint
Complaints Policy
Complaints Procedure
Whistle Blowing Policy


Southport Reporter® is the
Registered Trade Mark of Patrick Trollope